首页 | 本学科首页   官方微博 | 高级检索  
检索        

前列腺特异性抗原集团普查是前列腺癌早期诊治的最佳途径
引用本文:赵雪俭,孔祥波,王伟华.前列腺特异性抗原集团普查是前列腺癌早期诊治的最佳途径[J].中华男科学杂志,2003,9(8):563-565,568.
作者姓名:赵雪俭  孔祥波  王伟华
作者单位:吉林大学前列腺疾病防治研究中心,吉林,长春,130021
摘    要:为在我国实现前列腺癌早期发现、早期诊断与治疗的目的 ,对 5 0岁以上男性进行PSA集团普查 ,以集团普查癌与临床前列腺癌进行对比分析 ,证明只有通过人群普查才能发现早期前列腺癌并为病人提供根治的机会。同时探讨了前列腺癌的治疗现状与存在的问题 ,对前列腺癌未来研究方向进行了展望

关 键 词:前列腺癌  集团普查  前列腺特异性抗原
文章编号:1009-3591(2003)08-0563-04

Mass Screening for Prostate Cancer is the Best Approach to Early Diagnosis and Treatment of Prostate Cancer
Xue-Jian Zhao,Xiang-Bo Kong,Wei-Hua Wang.Mass Screening for Prostate Cancer is the Best Approach to Early Diagnosis and Treatment of Prostate Cancer[J].National Journal of Andrology,2003,9(8):563-565,568.
Authors:Xue-Jian Zhao  Xiang-Bo Kong  Wei-Hua Wang
Institution:Prostate Diseases Prevention and Treatment Research Centre, Jilin University, Changchun, Jilin 130021, China.
Abstract:To achieve the goal of early detection, diagnosis and treatment of prostate cancer in China, mass screening for prostate cancer using serum prostate specific antigen (PSA) has been performed in men over 50 years. We compared this result with the clinical cases. It proved that only through the mass screening can we really find the early stage prostate cancer and be given the chance of curing the cancer. We also investigated the current treatment situation and problems and figured out the further direction on the prostate cancer research.
Keywords:Prostate cancer  Mass screening  Prostate specific antigen
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号